Search Results

Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma.

• Authors : Elstrom RL; Center for Lymphoma and Myeloma, Weill Cornell Medical College, New York, NY 10065, USA.; Andemariam B

Subjects: Antibodies, Monoclonal, Murine-Derived/Antibodies, Monoclonal, Murine-Derived/Antibodies, Monoclonal, Murine-Derived/*administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Boronic Acids/Boronic Acids/Boronic Acids/*administration & dosage

• Source: Leukemia & lymphoma [Leuk Lymphoma] 2012 Aug; Vol. 53 (8), pp. 1469-73.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print Cited Medium: Internet ISSN: 1029-2403

Record details

Immunotherapy with interleukin-18 in combination with preoperative chemotherapy with ifosfamide effectively inhibits postoperative progression of pulmonary metastases in a mouse osteosarcoma model.

• Authors : Yamada N; Department of Pathology, Institute for Advanced Medical Sciences, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan. ; Hata M

Subjects: Bone Neoplasms/Bone Neoplasms/Bone Neoplasms/*immunology ; Ifosfamide/Ifosfamide/Ifosfamide/*therapeutic use ; Immunotherapy/Immunotherapy/Immunotherapy/*methods

• Source: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine [Tumour Biol] 2009; Vol. 30 (4), pp. 176-84. Date of Electronic Publication: Publisher: IOS Press Country of Publication: Netherlands NLM ID: 8409922 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.

• Authors : Indrová M; Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.; Bubeník J

Subjects: Immunotherapy* ; Repressor Proteins*; Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*therapeutic use

• Source: International journal of oncology [Int J Oncol] 2003 Mar; Vol. 22 (3), pp. 691-5.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print Cited Medium: Print ISSN: 1019-6439 (Print)

Record details

Progress in histology specific treatments in soft tissue sarcoma.

• Authors : Radaelli, Stefano; Merlini, Alessandra; Khan, Misbah

Subjects: THERAPEUTICS; SARCOMA; NEOADJUVANT chemotherapy

• Source: Expert Review of Anticancer Therapy; Sep2024, Vol. 24 Issue 9, p845-868, 24p

Record details

Research Conducted at Taipei Veterans General Hospital Has Provided New Information about Head and Neck Cancer (Paclitaxel-ifosfamide-based Therapy As Salvage Treatment In Platinum-resistant Recurrent/metastatic Head and Neck Cancer).

• Source: Immunotherapy Weekly; 8/6/2024, p881-881, 1p

Record details

Studies from AntiCancer Inc. Describe New Findings in Soft Tissue Sarcomas (Olaratumab Combined With Doxorubicin and Ifosfamide Overcomes Individual Doxorubicin and Olaratumab Resistance of an Undifferentiated Soft-tissue Sarcoma In a Pdox ...)

• Source: Immunotherapy Weekly. May 22, 2019, 6195

Record details

Study Data from Cancer Center Irvine Update Understanding of Soft Tissue Sarcomas (A pilot study of first-line olaratumab, doxorubicin and ifosfamide in patients with metastatic soft tissue sarcoma)

• Source: Immunotherapy Weekly. August 28, 2019, 5651

Record details

Metastatic penile squamous cell carcinoma with dramatic response to combined checkpoint blockade with ipilimumab and nivolumab.

• Authors : Baweja, Abinav; Mar, Nataliya

Subjects: ANTINEOPLASTIC agents; APOPTOSIS; CANCER chemotherapy

• Source: Journal of Oncology Pharmacy Practice; Jan2021, Vol. 27 Issue 1, p212-215, 4p

Record details

Immunotherapy with Interleukin-18 in Combination with Preoperative Chemotherapy with Ifosfamide Effectively Inhibits Postoperative Progression of Pulmonary Metastases in a Mouse Osteosarcoma Model.

• Authors : Yamada, Naoko; Hata, Masaki; Ohyama, Hideki

• Source: Tumor Biology (Springer Science & Business Media B.V.); 2009, Vol. 30 Issue 4, p176-184, 9p, 1 Chart, 7 Graphs

Record details

Systemic Treatment for Adults with Synovial Sarcoma.

• Authors : Desar, Ingrid M. E.; Fleuren, Emmy D. G.; van der Graaf, Winette T. A.

Subjects: ANTINEOPLASTIC agents; DOXORUBICIN; HETEROCYCLIC compounds

• Source: Current Treatment Options in Oncology; Feb2018, Vol. 19 Issue 2, p0-0, 1p

Record details